Precision BioSciences to Take part in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences By Investing.com
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a medical stage gene enhancing…
Guggenheim cuts 5 Beneath shares goal amid comp gross sales woes By Investing.com
On Wednesday, Guggenheim maintained a Purchase ranking on 5 Beneath (NASDAQ:) however…
ServiceNow downgraded at Guggenheim as a result of ‘materials threat within the inventory’ By Investing.com
Guggenheim analysts have downgraded ServiceNow (NYSE:) to Promote from Impartial, and set…
